Skip to content

Xencor XNCR Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Janux Therapeutics logo
Janux TherapeuticsJANX
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
Absci Corporation logo
Absci CorporationABSI
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's operating lease right-of-use assets in other assets?
Xencor (XNCR) reported operating lease right-of-use assets in other assets of $36.82M in Q1 2026.
How has Xencor's operating lease right-of-use assets in other assets changed year-over-year?
Xencor's operating lease right-of-use assets in other assets decreased by 2.2% year-over-year, from $37.65M to $36.82M.
What is the long-term trend for Xencor's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Xencor's operating lease right-of-use assets in other assets has grown at a 28.8% compound annual growth rate (CAGR), from $10.6M to $37.59M.